Login / Signup
Lily Price
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 2
Top Topics
Double Blind
Clinical Trial
High Dose
Top Venues
Pharmacotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lily Price
,
Lisa Garrity
,
Sarah R Stiehl
Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Pharmacotherapy
44 (5) (2024)
Lily Price
,
Lisa Garrity
,
Sarah R Stiehl
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution.
Pharmacotherapy
(2023)